Value of Whole Body MRI and Dynamic Contrast Enhanced MRI in the Diagnosis, Follow-up and Evaluation of Disease Activity and Extent in Multiple Myeloma
Overview
Affiliations
Purpose: To evaluate the significance of dynamic contrast enhanced MRI (DCE-MRI) and whole body MRI (WB-MRI) in the diagnosis, prognosis and assessment of therapy for patients with monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma (MM).
Materials And Methods: The retrospective study includes 219 patients providing 463 WB-MRI and DCE-MRI investigations for the subgroups MGUS (n=70), MM active disease (n=126; this includes 70 patients with new diagnosis of MM, according to the International Staging System (ISS): 41.4% ISS stage I, 20.0% ISS stage II, 7.1% ISS stage III, 31.4% insufficient for staging; and 56 patients with '(re-)active disease': 16.07% relapse, 32.14% progressive disease and 51.79% stable disease) and MM remission (n=23; 60.87% complete remission, 17.39% very good partial remission and 21.74% partial remission). Investigations of patients with hereditary multiple exostoses (n=5), neurofibromatosis (n=7) and healthy persons (n=9) were added as control subjects (n=21). WB-MRI evaluation was done by evaluating thirteen skeletal regions, providing a 'skeletal score'. DCE-MRI images of the spine, were analyzed with regions-of-interest and time-intensity-curves (TIC).
Results: All TIC parameters can significantly differentiate between the predefined subgroups (p<0.001). One hundred days after autologous stem cell transplantation a 75% decrease of the slope wash-in value (p<0.001) can be seen. A cubic regression trend between 'skeletal score' and slope wash-in (adj.R(2)=0.412) could demonstrate a significant increase bone marrow perfusion if MM affects more than 10 skeletal regions (p<0.001), associated with a poorer prognosis (p<0.001).
Conclusion: DCE-MRI evaluation of the spine is useful for diagnosis of MM, follow-up after stem cell transplantation and evaluation of disease activity. A combined evaluation with WB-MRI and DCE-MRI provides additional micro-vascular information on the morphologic lesions and could help categorize patients with MM in two different groups to offer useful therapeutic and prognostic advise.
Liu Y, Huang W, Yang Y, Cai W, Sun Z Am J Nucl Med Mol Imaging. 2024; 14(4):208-229.
PMID: 39309415 PMC: 11411189. DOI: 10.62347/NLLV9295.
Den Berghe T, Verberckmoes B, Kint N, Wallaert S, De Vos N, Algoet C Insights Imaging. 2024; 15(1):106.
PMID: 38597979 PMC: 11006637. DOI: 10.1186/s13244-024-01672-1.
Jamet B, Carlier T, Bailly C, Bodet-Milin C, Monnet A, Frampas E Eur Radiol. 2023; 33(9):6438-6447.
PMID: 37022439 DOI: 10.1007/s00330-023-09593-1.
X-ray and MRI Correlation of Bone Tumors Using Histopathology As Gold Standard.
Azad H, Ahmed A, Zafar I, Bhutta M, Rabbani M, Kc H Cureus. 2022; 14(7):e27262.
PMID: 36039258 PMC: 9403219. DOI: 10.7759/cureus.27262.
Den Berghe T, Verstraete K, Lecouvet F, Lejoly M, Dutoit J Skeletal Radiol. 2021; 51(1):101-122.
PMID: 34523007 DOI: 10.1007/s00256-021-03903-8.